Evidence map›Paper›PMID 40861814›Full record

ReviewJournal of Cancer2025

H3K14: A histone site closely related to diseases.

Chenyu Fan, Feng Zeng, Yan Lei, Qian He, Kun Liu, Juan Xu, Yanhong Zhou

Abstract readReview
In one paragraph

Review in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chenyu FanDepartment of critical care medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan 410013, China.
Feng ZengCancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan 410011, China.
Yan LeiDepartment of Blood Transfusion, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan 410013, China.
Qian HeDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan 410013, China.
Kun LiuDepartment of Neurosurgery, The Second People's Hospital of Hunan Province (Brain Hospital of Hunan Province), Clinical Medical School, Hunan University of Chinese Medicine, Changsha Hunan, 410007, China.
Juan XuDepartment of critical care medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan 410013, China.
Yanhong ZhouCancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan 410011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone H3K14 is a crucial site for histone H3 modifications, which are intimately connected to processes such as DNA replication, gene expression, and transcription. Modifications at H3K14 can lead to damage within the human body. Specifically, the acetylation of H3K14 influences immune system function, often linking to conditions like tumor inflammation and immune-related diseases. Lately, H3K14 has garnered significant attention across various scientific disciplines. This review outlines how H3K14 acetylation impacts DNA replication, enhances gene expression, and influences T cell development and activation. Furthermore, the combination of H3K14 acetylation with propionylation and butyration can also stimulate gene expression. In contrast, H3K14 methylation hinders DNA replication, while H3K14 ubiquitination affects both gene expression and transcriptional activity. The review also discusses the regulation of H3K14 by non-coding RNA, histone acetyltransferases, histone deacetylases, nuclear proteins, and pharmaceutical compounds. It explores the relationship between H3K14 and the diagnosis, onset, and treatment of diseases. By doing so, this review aims to offer a fresh perspective for a comprehensive understanding of H3K14's functions.

Indexed as

acetylation modificationDNA repairH3K14methylation modificationtranscription

Identifiers

PMID40861814
PMCPMC12374959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.